Filing Analysis
Regulation FD Disclosure
Filed May 07, 2026
LOW
Apyx Medical Corporation furnished its first quarter 2026 financial results via a press release on May 7, 2026. The filing covers the three-month period ended March 31, 2026.
Key Facts
- Earnings release for Q1 ended March 31, 2026
- Filed under Item 2.02 (Results of Operations and Financial Condition)
- Press release included as Exhibit 99.1
- Matthew Hill, CFO, signed the filing
Regulation FD Disclosure
Filed Mar 10, 2026
LOW
Apyx Medical Corporation reported its financial results for the fourth quarter and full year ended December 31, 2025, via a press release on March 10, 2026.
Key Facts
- The company reported results for the fourth quarter and fiscal year ended December 31, 2025
- The information was furnished under Item 2.02 Results of Operations and Financial Condition
- The full press release is included as Exhibit 99.1
- The filing was signed by Matthew Hill, Chief Financial Officer
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.